For medicine, bioprinting is a necessity and an inevitability. The demand for organs will undoubtedly continue to climb with the global median age. Yet what hurdles lie in the way of creating a renewable supply? One major engineering obstacle is properly seeding and feeding the culture in order to create a functional organ. This is because complex tissues are composed of many different types of cells precisely arranged in 3 dimensions. The approaches can be broadly divided between those using lasers and those that do not, those with scaffolds and those without. The number of possibilities multiplies when one takes into account choices in materials, growth and differentiation factors, and the types of cells one is using. Bioprinting will be a boon to transplant patients and pharmaceutical testing.
Currently, osteoarthritis (OA) is considered to be the most frequent form of arthritis in humans, and the current global market in joint replacements—the most widely recognized treatment—is estimated to be in excess of €7 billion. […]
The future of post-operative pain management might not involve pills — it might not involve medication at all. For the first time, hospitals are exploring an effective substitute that bears no risk of addiction: virtual […]
Patients afflicted with chronic pain might wish for another body but it turns out that sitting next to an image of their own body could do the job. A virtual reality “out of body” illusion […]